109 results on '"Wormald, Peter‐John"'
Search Results
2. Staphylococcus aureus Biofilm-Secreted Factors Cause Mucosal Damage, Mast Cell Infiltration, and Goblet Cell Hyperplasia in a Rat Rhinosinusitis Model.
- Author
-
Houtak G, Nepal R, Bouras G, Shaghayegh G, Bennett C, Finnie J, Fenix K, Psaltis AJ, Wormald PJ, and Vreugde S
- Subjects
- Humans, Rats, Animals, Goblet Cells pathology, Staphylococcus aureus, Hyperplasia pathology, Mast Cells pathology, Biofilms, Chronic Disease, Rhinosinusitis, Rhinitis pathology, Sinusitis pathology
- Abstract
Chronic rhinosinusitis (CRS) is an inflammatory condition of the sinonasal mucosa. Despite being a common health issue, the exact cause of CRS is yet to be understood. However, research suggests that Staphylococcus aureus , particularly in its biofilm form, is associated with the disease. This study aimed to investigate the impact of long-term exposure to secreted factors of Staphylococcus aureus biofilm (SABSFs), harvested from clinical isolates of non-CRS carrier and CRS patients, on the nasal mucosa in a rat model. Animals were randomised (n = 5/group) to receive daily intranasal instillations of 40 μL (200 μg/μL) SABSFs for 28 days or vehicle control. The sinonasal samples were analysed through histopathology and transcriptome profiling. The results showed that all three intervention groups displayed significant lymphocytic infiltration ( p ≤ 0.05). However, only the SABSFs collected from the CRSwNP patient caused significant mucosal damage, mast cell infiltration, and goblet cell hyperplasia compared to the control. The transcriptomics results indicated that SABSFs significantly enriched multiple inflammatory pathways and showed distinct transcriptional expression differences between the control group and the SABSFs collected from CRS patients ( p ≤ 0.05). Additionally, the SABSF challenges induced the expression of IgA and IgG but not IgE. This in vivo study indicates that long-term exposure to SABSFs leads to an inflammatory response in the nasal mucosa with increased severity for S. aureus isolated from a CRSwNP patient. Moreover, exposure to SABSFs does not induce local production of IgE.
- Published
- 2024
- Full Text
- View/download PDF
3. A Novel Model of Staphylococcus aureus -Induced Lymphoplasmacytic Rhinosinusitis in Rats.
- Author
-
Murphy W, Liu S, Hon K, Finnie J, Bouras GS, Feizi S, Houtak G, Shaghayegh G, Vyskocil E, Wormald PJ, Vreugde S, and Psaltis AJ
- Subjects
- Humans, Rats, Animals, Staphylococcus aureus, Rats, Sprague-Dawley, Inflammation complications, Saline Solution, Chronic Disease, Rhinosinusitis, Rhinitis complications, Sinusitis complications, Staphylococcal Infections drug therapy
- Abstract
Chronic rhinosinusitis (CRS) is characterized by sinonasal mucosal inflammation. Staphylococcus aureus (S. aureus) is associated with severe CRS phenotypes. Different animal models have been proposed to study the association of CRS and S. aureus . However, current animal models are expensive due to the use of large animals, have high barriers to ethics approval, or require invasive surgical intervention, necessitating a need for a model that can overcome these limitations. This study aimed at establishing a reliable and efficient rat lymphoplasmacytic inflammatory model for rhinosinusitis. Sprague Dawley rats received a daily intranasal application of 20 μL of saline, S. aureus CI-182 exoprotein (250 μg/mL), or exoprotein CI-182 in combination with S. aureus clinical isolate (CI-908 or CI-913) 10
8 colony-forming unit (CFU)/mL. The rats' sinuses were harvested at 1 and 2 weeks post-intervention. The CFU and histopathologic examination of inflammation were evaluated. S. aureus clinical isolates CI-908 or CI-913 in combination with the exoprotein (CI-182) had higher CFUs and caused persistently higher inflammation at both the 1 and 2-week post-intervention compared to the exoprotein and saline group. The observed inflammatory cell type was lymphoplasmacytic. This study provided evidence that the combination of a S. aureus exoprotein with S. aureus induces inflammation that persists for a minimum of two weeks post-intervention. This model is the first known animal model to create the lymphoplasmacytic inflammation subtype seen in CRS patients. This offers a cost-effective, accessible, non-invasive, and easy-to-replicate model to study the causes and treatment of such inflammation.- Published
- 2024
- Full Text
- View/download PDF
4. S. aureus biofilm metabolic activity correlates positively with patients' eosinophil frequencies and disease severity in chronic rhinosinusitis.
- Author
-
Shaghayegh G, Cooksley C, Bouras G, Houtak G, Nepal R, Psaltis AJ, Wormald PJ, and Vreugde S
- Subjects
- Humans, Staphylococcus aureus genetics, Eosinophils pathology, Nasal Mucosa, Biofilms, Patient Acuity, Inflammation pathology, Chronic Disease, Methicillin-Resistant Staphylococcus aureus, Rhinitis pathology, Rhinosinusitis, Sinusitis pathology
- Abstract
Chronic rhinosinusitis (CRS) is a persistent inflammation of the sinus mucosa. Recalcitrant CRS patients are unresponsive to medical and surgical interventions and often present with nasal polyps, tissue eosinophilia, and Staphylococcus aureus dominant mucosal biofilms. However, S. aureus sinonasal mucosal colonisation occurs in the absence of inflammation, questioning the role of S. aureus in CRS pathogenesis. Here, we aimed to investigate the relationship between S. aureus biofilm metabolic activity and virulence genes, innate immune cells, and disease severity in CRS. Biospecimens, including sinonasal tissue and nasal swabs, and clinical datasets, including disease severity scores, were obtained from CRS patients and non-CRS controls. S. aureus isolates were grown into biofilms in vitro, characterised, and sequenced. The patients' innate immune response was evaluated using flow cytometry. S. aureus was isolated in 6/19 (31.58%) controls and 23/53 (43.40%) CRS patients of 72 recruited patients. We found increased S. aureus biofilm metabolic activity in relation to increased eosinophil cell frequencies and disease severity in recalcitrant CRS cases. Mast cell frequencies were higher in tissue samples of patients carrying S. aureus harbouring lukF.PV, sea, and fnbB genes. Patients with S. aureus harbouring lukF.PV and sdrE genes had more severe disease. This offers insights into the pathophysiology of CRS and could lead to the development of more targeted therapies., Competing Interests: Declaration of competing interest There is no conflict of interest., (Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
5. Wound healing in endoscopic sinus surgery: Phase 1 clinical trial evaluating the role of Chitogel with adjuvants.
- Author
-
Vediappan RS, Bennett C, Cooksley C, Bassiouni A, Scott JR, Al Suliman YA, Lumyongsatien J, Moratti S, Psaltis AJ, Vreugde S, and Wormald PJ
- Subjects
- Humans, Wound Healing, Endoscopy methods, Chronic Disease, Treatment Outcome, Paranasal Sinuses surgery, Sinusitis surgery, Nasal Surgical Procedures methods, Rhinitis surgery
- Abstract
Objectives: This study aimed to determine the safety and efficacy of Chitogel, with and without Deferiprone (Def) and Gallium Protoporphyrin (GaPP), as a promoter of wound healing to improve surgical outcomes after endoscopic sinus susgery., Design: A double-blinded, randomised control human clinical trial was conducted in patients undergoing ESS as a treatment for chronic rhinosinusitis. Participants underwent functional ESS or FESS with drill out as required and were randomised to receive test product Chitogel, Chitogel in combination with Def or Def-GaPP versus no packing (control)., Setting: Ostial stenosis and persistent inflammation are the main reasons for revision endoscopic sinus surgery (ESS). Post-operative (PO) dressings can improve PO wound healing and patient outcomes after ESS., Participants: Eighty two patients were included in this study with 79 patients completing the study with 40 undergoing full house FESS and 39 FESS plus frontal drillout., Main Outcome Measures: Patients were followed up at 2, 6 and 12 weeks PO, and outcome scores such as SNOT-22, VAS and LKS, pre and post-surgery (12 weeks) were compared., Results: Seventy nine patients completed the study, there was a significant reduction in SNOT-22 score and improvement of VAS at 12 weeks in patients treated with Chitogel compared to control (p < .05). In those patients, the mean ostium area for the Chitogel and the Chitogel + Def + GaPP groups was higher across all three sinuses compared to the no-treatment control group, without statistical significance. Sphenoid sinus ostium was significantly more patent in patients treated with Chitogel compared to the control at the 12-week time point (p < .05)., Conclusion: Chitogel as a PO dressing after ESS results in the best patient-reported symptom scores and objective measurements. The combination of Def and GaPP to Chitogel though proving safe, had no effect on the ostium patency or mucosal healing., (© 2022 The Authors. Clinical Otolaryngology published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
6. Staphylococcal protein A modulates inflammation by inducing interferon signaling in human nasal epithelial cells.
- Author
-
Hu H, Liu S, Hon K, Psaltis AJ, Wormald PJ, and Vreugde S
- Subjects
- Humans, Animals, Mice, Staphylococcal Protein A, Staphylococcus aureus physiology, Inflammation, Interferons, Epithelial Cells, Chronic Disease, Rhinitis, Nasal Polyps, Sinusitis, Staphylococcal Infections
- Abstract
Objective and Design: Staphylococcus aureus (S. aureus) is one of the leading causes of human respiratory tract infections. The function of Staphylococcal protein A (SpA), expressed on the S. aureus bacterial membrane and released in the environment, on human nasal epithelial cells (HNECs) have not been fully elucidated. In this study, we tested the SpA expression in S. aureus from chronic rhinosinusitis patients and investigated the effects of SpA on HNECs inflammation through Interferon Gamma Receptor 1(IFNGR1)/phosphorylated Janus Kinase 2 (p-JAK2) pathway., Methods: RNA profiling was performed to investigate inflammatory activation in a S. aureus chronic rhinosinusitis (CRS) mouse model. SpA release by S. aureus clinical isolates was determined using ELISA. The effect of purified SpA and SpA enriched conditioned media from S. aureus clinical isolates on HNECs cytotoxicity, apoptosis and release of inflammatory cytokines was evaluated using lactate dehydrogenase assays, and flow cytometry. SpA dependent IFNGR1 and p-JAK2 expression were assessed by qPCR, immunofluorescence and western blot in HNECs., Results: 49 genes were significantly induced in S. aureus CRS mice indicative of activation of interferon signaling. SpA release was significantly higher in S. aureus clinical isolates from chronic rhinosinusitis with nasal polyps (CRSwNP) patients. Purified SpA significantly increased IFNGR1 mRNA and protein expression in HNECs. SpA induced cytotoxic effects and induced the release of Interleukin-6 (IL-6) and IL-8 in an IFNGR1 dependent way., Conclusion: SpA induces interferon signaling through activation of the IFNGR1-JAK-2 pathway, which provides an understanding of how S. aureus SpA affects the inflammatory process in the upper airways., (© 2022. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
7. Chitogel following endoscopic sinus surgery promotes a healthy microbiome and reduces postoperative infections.
- Author
-
Megow A, Alsuliman Y, Bouras G, Menberu M, Vyskocil E, Vreugde S, and Wormald PJ
- Subjects
- Humans, Endoscopy, Postoperative Complications prevention & control, Chronic Disease, Treatment Outcome, Sinusitis surgery, Sinusitis microbiology, Paranasal Sinuses surgery, Paranasal Sinuses microbiology, Microbiota, Rhinitis surgery
- Abstract
Background: Postoperative infections following endoscopic sinus surgery (ESS) impair wound healing and lead to poor outcomes. The aim of this study is to assess the effectiveness of Chitogel to reduce postoperative infections and restore a healthy microbiome following ESS., Methods: In this double-blinded randomized control trial, 25 patients undergoing ESS were prospectively recruited. At the end of surgery, patients were randomized to receive Chitogel to one side of the sinuses (allowing the other side to serve as control). Patients underwent routine follow-up with nasoendoscopies performed at 2, 6, and 12 weeks postoperatively. Sinus ostial measurements, microbiology, and microbiome swabs from bilateral sides were collected intraoperatively and at 12 weeks postoperatively. Additional swabs were collected if infection was present., Results: Improved endoscopic appearance of the sinuses (p = 0.03) and ostial patency were noted on the Chitogel side compared with control at 12 weeks (p < 0.001). A significant decrease in infections on the Chitogel side (12.0%) compared with control (52.0%) (p = 0.005) was evident. Following the use of Chitogel, there was a significant increase in the combined relative abundance of commensals Corynebacterium and Cutibacterium (Propionibacterium) from 30.15% at baseline to 46.62% at 12 weeks compared with control (47.18% to 40.79%) (p.adj = 0.01)., Conclusion: Chitogel significantly improved both the nasoendoscopic appearance of the sinuses and sinus ostial patency at 12 weeks postoperatively. Chitogel used following ESS helps restore an improved microbiome resulting in an increase in the relative abundance of commensals Corynebacterium and Cutibacterium (Propionibacterium). A significant decrease in postoperative infections was noted following use of Chitogel., (© 2022 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.)
- Published
- 2022
- Full Text
- View/download PDF
8. Prophages encoding human immune evasion cluster genes are enriched in Staphylococcus aureus isolated from chronic rhinosinusitis patients with nasal polyps.
- Author
-
Nepal R, Houtak G, Shaghayegh G, Bouras G, Shearwin K, Psaltis AJ, Wormald PJ, and Vreugde S
- Subjects
- Base Composition, Drug Resistance, Bacterial, Genome Size, Genome, Bacterial, Humans, Immune Evasion, Nasal Polyps diagnostic imaging, Phylogeny, Rhinitis diagnostic imaging, Severity of Illness Index, Sinusitis diagnostic imaging, Staphylococcus aureus classification, Staphylococcus aureus genetics, Tomography, X-Ray Computed, Virulence Factors genetics, Nasal Polyps microbiology, Prophages genetics, Rhinitis microbiology, Sinusitis microbiology, Staphylococcus aureus virology
- Abstract
Prophages affect bacterial fitness on multiple levels. These include bacterial infectivity, toxin secretion, virulence regulation, surface modification, immune stimulation and evasion and microbiome competition. Lysogenic conversion arms bacteria with novel accessory functions thereby increasing bacterial fitness, host adaptation and persistence, and antibiotic resistance. These properties allow the bacteria to occupy a niche long term and can contribute to chronic infections and inflammation such as chronic rhinosinusitis (CRS). In this study, we aimed to identify and characterize prophages present in Staphylococcus aureus from patients suffering from CRS in relation to CRS disease phenotype and severity. Prophage regions were identified using PHASTER. Various in silico tools like ResFinder and VF Analyzer were used to detect virulence genes and antibiotic resistance genes respectively. Progressive MAUVE and maximum likelihood were used for multiple sequence alignment and phylogenetics of prophages respectively. Disease severity of CRS patients was measured using computed tomography Lund-Mackay scores. Fifty-eight S. aureus clinical isolates (CIs) were obtained from 28 CRS patients without nasal polyp (CRSsNP) and 30 CRS patients with nasal polyp (CRSwNP). All CIs carried at least one prophage (average=3.6) and prophages contributed up to 7.7 % of the bacterial genome. Phage integrase genes were found in 55/58 (~95 %) S. aureus strains and 97/211 (~46 %) prophages. Prophages belonging to Sa3int integrase group (phiNM3, JS01, phiN315) (39/97, 40%) and Sa2int (phi2958PVL) (14/97, 14%) were the most prevalent prophages and harboured multiple virulence genes such as sak, scn, chp, luk E/D, sea . Intact prophages were more frequently identified in CRSwNP than in CRSsNP ( P =0.0021). Intact prophages belonging to the Sa3int group were more frequent in CRSwNP than in CRSsNP ( P =0.0008) and intact phiNM3 were exclusively found in CRSwNP patients ( P =0.007). Our results expand the knowledge of prophages in S. aureus isolated from CRS patients and their possible role in disease development. These findings provide a platform for future investigations into potential tripartite associations between bacteria-prophage-human immune system, S. aureus evolution and CRS disease pathophysiology.
- Published
- 2021
- Full Text
- View/download PDF
9. Metallothionein-3 is a clinical biomarker for tissue zinc levels in nasal mucosa.
- Author
-
Suzuki M, Ramezanpour M, Cooksley C, Ogi K, Psaltis AJ, Nakamaru Y, Homma A, Wormald PJ, and Vreugde S
- Subjects
- Biomarkers, Chronic Disease, Epithelial Cells metabolism, Humans, Metallothionein 3 metabolism, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Metallothionein 3 genetics, Nasal Mucosa metabolism, Nasal Polyps metabolism, Rhinitis metabolism, Sinusitis metabolism, Zinc metabolism
- Abstract
Objective: Recently, depleted tissue zinc levels were found in nasal mucosa from patients with chronic rhinosinusitis (CRS) in correlation with tissue eosinophilia, however, no clinical biomarkers for tissue zinc levels have been identified. Metallothionein-3 (MT3) is an intracellular zinc chelator and previous data showed MT3 mRNA levels to be reduced in CRS patients with nasal polyps (CRSwNP). In this study, we examined the correlation between MT3 expression and zinc levels in nasal mucosa and primary human nasal epithelial cells (HNECs) to investigate whether MT3 could be a clinical biomarker for tissue zinc levels., Method: Tissue was harvested from 36 patients and mounted on tissue micro-array (TMA) slides. MT3 expression and tissue zinc fluorescence intensity were measured at different areas within the mucosa (surface epithelium and lamina propria) and compared between controls, CRSwNP and CRS without nasal polyps (CRSsNP) patients. MT3 mRNA and protein expression were examined in zinc-depleted HNECs by qPCR and immunofluorescence microscopy., Results: MT3 expression in CRSwNP was significantly decreased in both surface epithelium (p<0.001 to controls) and lamina propria (p = 0.0491 to controls). There was a significant positive correlation between tissue zinc levels and MT3 expression in nasal mucosa (r = 0.45, p = 0.007). In zinc-deplete HNECs, MT3 expression was significantly decreased at mRNA (p = 0.02) and protein level (p<0.01). There was a significant positive correlation between tissue zinc levels and MT3 expression within individual HNECs (r = 0.59, p<0.001)., Conclusions: MT3 expression reflects intramucosal zinc levels in both nasal mucosa and HNECs indicating MT3 could be used as a clinical biomarker for monitoring intracellular zinc levels in the nasal mucosa., (Copyright © 2021. Published by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF
10. International consensus statement on allergy and rhinology: rhinosinusitis 2021.
- Author
-
Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU, Poetker DM, Soler Z, Welch KC, Wise SK, Adappa N, Alt JA, Anselmo-Lima WT, Bachert C, Baroody FM, Batra PS, Bernal-Sprekelsen M, Beswick D, Bhattacharyya N, Chandra RK, Chang EH, Chiu A, Chowdhury N, Citardi MJ, Cohen NA, Conley DB, DelGaudio J, Desrosiers M, Douglas R, Eloy JA, Fokkens WJ, Gray ST, Gudis DA, Hamilos DL, Han JK, Harvey R, Hellings P, Holbrook EH, Hopkins C, Hwang P, Javer AR, Jiang RS, Kennedy D, Kern R, Laidlaw T, Lal D, Lane A, Lee HM, Lee JT, Levy JM, Lin SY, Lund V, McMains KC, Metson R, Mullol J, Naclerio R, Oakley G, Otori N, Palmer JN, Parikh SR, Passali D, Patel Z, Peters A, Philpott C, Psaltis AJ, Ramakrishnan VR, Ramanathan M Jr, Roh HJ, Rudmik L, Sacks R, Schlosser RJ, Sedaghat AR, Senior BA, Sindwani R, Smith K, Snidvongs K, Stewart M, Suh JD, Tan BK, Turner JH, van Drunen CM, Voegels R, Wang Y, Woodworth BA, Wormald PJ, Wright ED, Yan C, Zhang L, and Zhou B
- Subjects
- Consensus, Humans, Rhinitis therapy, Rhinitis, Allergic, Sinusitis therapy
- Abstract
I., Executive Summary: BACKGROUND: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR-RS-2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence-based findings of the document., Methods: ICAR-RS presents over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary., Results: ICAR-RS-2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence-based management algorithm is provided., Conclusion: This ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS., (© 2021 ARS-AAOA, LLC.)
- Published
- 2021
- Full Text
- View/download PDF
11. Proteomic analysis of nasal mucus samples of healthy patients and patients with chronic rhinosinusitis.
- Author
-
Kao SS, Bassiouni A, Ramezanpour M, Finnie J, Chegeni N, Colella AD, Chataway TK, Wormald PJ, Vreugde S, and Psaltis AJ
- Subjects
- Adult, Aged, Chronic Disease, Female, Humans, Male, Middle Aged, Proteomics, Mucus metabolism, Nasal Mucosa metabolism, Proteome metabolism, Rhinitis metabolism, Sinusitis metabolism
- Abstract
Background: Chronic rhinosinusitis (CRS) has a complex and multifactorial pathogenesis with a heterogeneous inflammatory profile. Proteomic analysis of nasal mucus may enable further understanding of protein abundances and biologic processes present in CRS and its endotypes compared with in healthy patients., Objective: Our aim was to determine differences in the nasal mucus proteome of healthy patients and patients with CRS., Methods: Nasal mucus was obtained from healthy patients, patients with CRS without nasal polyps (CRSsNP), and patients with CRS with nasal polyps (CRSwNP) before surgery. Gel electrophoresis was performed to fractionate the complex protein extracts before mass spectrometry analysis. Gene set enrichment analysis was performed on differentially expressed proteins., Results: A total of 33 patients were included in this study (12 healthy, 10 with CRSsNP, and 11 with CRSwNP). In all, 1142 proteins were identified in mucus samples from healthy patients, 761 in mucus samples from patients with CRSsNP, and 998 in mucus samples from patients with CRSwNP. Dysfunction in immunologic pathways, reduced cellular signaling, and increased cellular metabolism with associated tissue remodeling pathways were present in patients with CRS compared with in healthy patients., Conclusion: Significant downregulation of mucosal immunity and antioxidant pathways with increased tissue modeling processes may account for the clinical manifestations of CRS. Ultimately, the differing proteome and biologic processes provide further insight into CRS pathogenesis and its endotypes., (Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
12. Barrier disruptive effects of mucus isolated from chronic rhinosinusitis patients.
- Author
-
Kao SS, Ramezanpour M, Bassiouni A, Finnie J, Wormald PJ, Vreugde S, and Psaltis AJ
- Subjects
- Cells, Cultured, Chronic Disease, Female, Humans, Male, Mucus metabolism, Nasal Mucosa pathology, Permeability, Rhinitis pathology, Sinusitis pathology
- Published
- 2020
- Full Text
- View/download PDF
13. Manuka honey sinus irrigations in recalcitrant chronic rhinosinusitis: phase 1 randomized, single-blinded, placebo-controlled trial.
- Author
-
Ooi ML, Jothin A, Bennett C, Ooi EH, Vreugde S, Psaltis AJ, and Wormald PJ
- Subjects
- Adult, Aged, Aged, 80 and over, Bacteria isolation & purification, Chronic Disease, Female, Humans, Leptospermum, Male, Middle Aged, Nasal Lavage, Paranasal Sinuses microbiology, Rhinitis microbiology, Single-Blind Method, Sinusitis microbiology, Anti-Bacterial Agents therapeutic use, Apitherapy, Honey, Rhinitis therapy, Sinusitis therapy
- Abstract
Background: Manuka honey (MH) has significant antibiofilm activity in vitro and in vivo against Staphylococcus aureus, methicillin-resistant S aureus (MRSA), and Pseudomonas aeruginosa. This is the first randomized, single-blinded, placebo-controlled phase 1 clinical trial investigating the safety and preliminary efficacy of MH with augmented methylglyoxal (MGO) rinses in recalcitrant chronic rhinosinusitis (CRS)., Methods: Patients were included after previously undergoing endoscopic sinus surgery and presenting with signs and symptoms of sinus infection with positive bacterial cultures on sinus swabs. Patients were randomized to receive 14 days of twice-daily 16.5% MH + 1.3 mg/mL MGO sinonasal rinses and concurrent 10 days of placebo tablets (MH), or 14 days of twice-daily saline sinonasal rinses and concurrent 10 days of culture-directed antibiotic therapy (CON). Safety observations included the University of Pennsylvania Smell Identification Test (UPSIT) and adverse-event (AE) reporting. Efficacy was assessed comparing microbiology results, Lund-Kennedy scores (LKSs), and symptom scores using the visual analog scale (VAS) and 22-item Sino-Nasal Outcome Test (SNOT-22)., Results: Twenty-five patients completed the study. MH demonstrated a good safety profile with no major AEs and no changes in UPSIT. Six of 10 (60%) MH patients had a reduction in bacterial culture rate with 1 of 10 of those having negative cultures, compared with 12 of 15 (80%) in the control group with 7 of 15 having negative cultures upon completion of the study., Conclusion: This study concludes that twice-daily 16.5% MH augmented with 1.3 mg/mL MGO sinonasal rinses alone for 14 days is safe but not superior to culture-directed oral antibiotics and twice-daily saline rinses., (© 2019 ARS-AAOA, LLC.)
- Published
- 2019
- Full Text
- View/download PDF
14. Nasal irrigation and ostial size: what works best?
- Author
-
Wormald PJ
- Subjects
- Chronic Disease, Humans, Nasal Polyps pathology, Nasal Sprays, Organ Size, Rhinitis pathology, Sinusitis pathology, Nasal Lavage methods, Nasal Polyps therapy, Paranasal Sinuses pathology, Rhinitis therapy, Sinusitis therapy, Sphenoid Bone anatomy & histology
- Published
- 2019
- Full Text
- View/download PDF
15. The presence of virus significantly associates with chronic rhinosinusitis disease severity.
- Author
-
Goggin RK, Bennett CA, Bialasiewicz S, Vediappan RS, Vreugde S, Wormald PJ, and Psaltis AJ
- Subjects
- Chronic Disease, Disease Susceptibility, Humans, Severity of Illness Index, Virus Diseases immunology, Virus Diseases virology, Rhinitis diagnosis, Rhinitis etiology, Sinusitis diagnosis, Sinusitis etiology, Virus Diseases complications
- Published
- 2019
- Full Text
- View/download PDF
16. In vitro characteristics of an airway barrier-disrupting factor secreted by Staphylococcus aureus.
- Author
-
Murphy J, Ramezanpour M, Drilling A, Roscioli E, Psaltis AJ, Wormald PJ, and Vreugde S
- Subjects
- Cells, Cultured, Chronic Disease, Culture Media, Conditioned metabolism, Electric Impedance, Enterotoxins metabolism, Hemolysin Proteins metabolism, Humans, Lipopolysaccharides metabolism, Nasal Mucosa pathology, Permeability, Rhinitis physiopathology, Sinusitis physiopathology, Staphylococcal Infections physiopathology, Teichoic Acids metabolism, Culture Media, Conditioned analysis, Nasal Mucosa metabolism, Rhinitis microbiology, Sinusitis microbiology, Staphylococcal Infections microbiology, Staphylococcus aureus physiology, Tight Junctions metabolism
- Abstract
Background: Staphylococcus aureus is a major contributor to the pathophysiology of chronic rhinosinusitis (CRS). Previous research has shown that S. aureus-secreted products disrupt the airway barrier., Methods: S. aureus ATCC 13565 and 25923 strains were grown at exponential, postexponential, and stationary phases. Microbial conditioned media (CM) was collected from the cultures and ultrafiltered (UF). Liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) was performed on the UF-CM. UF-CM was subjected to heat and protease treatment, size fractionation, and ultracentrifugation (UC) separation. Human nasal epithelial cells grown at air-liquid interface (HNEC-ALI) cultures were exposed to purified alpha hemolysin (Hla), staphylococcal enterotoxin A (SEA), lipoteichoic acid (LTA), and UF-CM. Barrier function outcomes were measured by transepithelial electrical resistance (TEER) and apparent permeability (Papp). UC fraction exposed cultures were subjected to immunofluorescence microscopy for tight junction (TJ) protein zonula occludens-1 (ZO-1)., Results: LC-ESI-MS/MS identified 107 proteins, with Hla being most abundant. Hla, SEA, and LTA did not alter the HNEC-ALI barrier as measured by TEER or Papp. Barrier disruption caused by UF-CM peaked in the postexponential phase, was sensitive to heat and protease treatment, >30-kDa in size, and enriched in the UC fraction. HNEC-ALI exposed to UF-CM and UC demonstrated loss of ZO-1 localization., Conclusion: These results suggest that the S. aureus factor responsible for TJ disruption in HNEC-ALI cultures is either a protein-macromolecule or a combination of secreted factors. The product is enriched in the UC fraction, suggesting it is associated with large structures such as membrane components or vesicles., (© 2018 ARS-AAOA, LLC.)
- Published
- 2019
- Full Text
- View/download PDF
17. Staphylococcus aureus small colony variants: Prevalence in chronic rhinosinusitis and induction by antibiotics.
- Author
-
Zhang G, Zhao Y, Hayes AJ, Psaltis AJ, Wormald PJ, and Vreugde S
- Subjects
- Chronic Disease, Humans, Prevalence, Staphylococcal Infections chemically induced, Staphylococcus aureus drug effects, Anti-Bacterial Agents adverse effects, Genetic Variation, Rhinitis microbiology, Sinusitis microbiology, Staphylococcus aureus genetics
- Published
- 2018
- Full Text
- View/download PDF
18. Tertiary lymphoid organs: A novel target in patients with chronic rhinosinusitis.
- Author
-
Paramasivan S, Lester S, Lau A, Ou J, Psaltis AJ, Wormald PJ, and Vreugde S
- Subjects
- Chronic Disease, Female, Humans, Male, Middle Aged, Nasal Polyps immunology, Rhinitis immunology, Sinusitis immunology, Tertiary Lymphoid Structures immunology
- Published
- 2018
- Full Text
- View/download PDF
19. Mucosal zinc deficiency in chronic rhinosinusitis with nasal polyposis contributes to barrier disruption and decreases ZO-1.
- Author
-
Murphy J, Ramezanpour M, Roscioli E, Psaltis AJ, Wormald PJ, and Vreugde S
- Subjects
- Chronic Disease, Humans, Mucous Membrane metabolism, Mucous Membrane pathology, Nasal Polyps, Rhinitis complications, Mucous Membrane chemistry, Rhinitis pathology, Sinusitis pathology, Zinc deficiency, Zonula Occludens-1 Protein metabolism
- Published
- 2018
- Full Text
- View/download PDF
20. Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients.
- Author
-
Zhang G, Zhao Y, Paramasivan S, Richter K, Morales S, Wormald PJ, and Vreugde S
- Subjects
- Anti-Bacterial Agents pharmacology, Chronic Disease, Humans, Phage Therapy, Staphylococcus aureus drug effects, Staphylococcus aureus isolation & purification, Drug Resistance, Multiple, Bacterial, Rhinitis microbiology, Sinusitis microbiology, Staphylococcal Infections microbiology, Staphylococcus Phages, Staphylococcus aureus growth & development
- Abstract
Background: Bacteriophage (phage) therapy has been proposed as an alternative to antibiotics. Phages have been shown to kill antibiotic resistant Staphylococcus aureus strains; however, it is unknown whether stress-induced antibiotic tolerance affects S. aureus susceptibility to phages. Our objective was to determine the effectiveness of 2 phages currently in clinical development, against antibiotic-resistant and induced antibiotic-tolerant clinical S. aureus isolates., Methods: Antibiotic tolerant S. aureus strains were induced by incubation with increasing concentrations of gentamicin, mupirocin, and ciprofloxacin over time and their susceptibility to 2 clinically relevant phages (Sa83 and Sa87) was assessed. In addition, phage susceptibility was tested in relation to the antibiotic sensitivity of 65 clinical S. aureus isolates, harvested from the sinonasal cavities of chronic rhinosinusitis (CRS) patients. Phage sensitivity was assessed using a plaque spot assay and by measuring optical density values to observe planktonic S. aureus growth in the presence of the phage. Alamar Blue assays were used to assess biofilm viability after phage treatment., Results: Frequency of antibiotic resistance amongst clinical S. aureus isolates was 90.7% (59/65) with 13 of 65 (20.0%) identified as multidrug-resistant. Tolerance to gentamicin, mupirocin, and ciprofloxacin was rapidly induced by incubation with increasing concentrations of respective antibiotics. There was no significant difference in phage sensitivity between antibiotic-sensitive and resistant/tolerant S. aureus clinical isolates in planktonic and biofilm form., Conclusion: Clinical S. aureus isolates from CRS patients have a high (20%) incidence of multidrug resistance. Antibiotic resistance or tolerance did not affect phage susceptibility of those isolates., (© 2017 ARS-AAOA, LLC.)
- Published
- 2018
- Full Text
- View/download PDF
21. Role of fungi in chronic rhinosinusitis through ITS sequencing.
- Author
-
Zhao YC, Bassiouni A, Tanjararak K, Vreugde S, Wormald PJ, and Psaltis AJ
- Subjects
- Biomass, Chronic Disease, DNA, Fungal analysis, Endoscopy, Female, Humans, Male, Microbiota, Nasal Mucosa microbiology, Polymerase Chain Reaction, Prospective Studies, Mycoses microbiology, Rhinitis microbiology, Sinusitis microbiology
- Abstract
Objective: Next-generation sequencing increases the sensitivity of fungal identification and may improve our understanding of the role that fungi play in sinus health and disease, which remains incompletely understood. We sequenced the internal transcribed spacer (ITS) amplicon to explore the role of the mycobiome in chronic rhinosinusitis (CRS)., Methods: Swabs were collected intraoperatively from the middle meatus of 90 patients (63 with CRS; 27 controls). DNA was extracted, and ITS amplicon concentration was measured using fluorometry. Internal transcribed spacer amplicons were sequenced on the Illumina MiSeq (Illumina Inc San Diego CA). Sequencing data were analyzed using QIIME., Results: Using conventional detection techniques of culture and histology, fungi only were identified in nine of 63 (14.3%) CRS patients (fungus-identified group); the remaining 54 CRS patients and all controls did not have fungus identified using the traditional techniques. This fungus-identified group had a significantly higher average ITS concentration and a significantly lower Shannon's diversity index compared to the other two groups. The most abundant organism sequenced was Aspergillus (35.22% of all sequences). Multivariate analysis showed that positive fungal detection using traditional techniques and computed tomography (CT) double densities were the most important clinical predictors of a high fungal biomass, whereas Lund-Mackay score, polyps, eosinophilia, and eosinophilic mucus were not significant in comparison., Conclusion: Fungal biomass estimated through ITS amplicon concentration correlated with traditional fungal detection techniques and CT double densities. Our results suggest that fungal dysbiosis only occurs in the sinuses of a selected subset of patients, and therefore could not be a universal determinant of sinus disease pathogenesis in all CRS patients., Level of Evidence: NA. Laryngoscope, 128:16-22, 2018., (© 2017 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
22. Naive and effector B-cell subtypes are increased in chronic rhinosinusitis with polyps.
- Author
-
Miljkovic D, Psaltis A, Wormald PJ, and Vreugde S
- Subjects
- Blood Circulation, Cell Separation, Chronic Disease, Flow Cytometry, Humans, Immunologic Memory, Inflammation, Nasal Polyps complications, Rhinitis complications, Sinusitis complications, B-Lymphocyte Subsets immunology, B-Lymphocytes immunology, Nasal Mucosa immunology, Nasal Polyps immunology, Plasma Cells immunology, Rhinitis immunology, Sinusitis immunology
- Abstract
Background: Recent studies demonstrated that B cells and their chemoattractants are elevated in the nasal mucosa of patients with chronic rhinosinusitis (CRS) with nasal polyposis (CRSwNP). However, the presence of naive B cells and of plasmablasts and memory B-cell subsets in the mucosa and periphery of the same patient with CRS is yet to be characterized., Objective: Here we sought to quantify naive, plasmablasts, and memory B cells in mucosal tissue and peripheral blood of patients with CRSwNP, patients with CRS without nasal polyps (CRSsNP), and control patients., Methods: Polyps, mucosa, and peripheral blood samples were prospectively collected from the patients with CRS and from the non-CRS controls. We used flow cytometry to distinguish among naive, plasmablast, and memory B cells in sinus tissue and peripheral blood., Results: A total of 45 patients were recruited for the study. The patients with CRSwNP had significantly increased mucosal B-cell numbers versus the controls (3.39 ± 4.05% versus 0.39 ± 1.05% of live cells; p < 0.01, Kruskal-Wallis test), which included naive B cells (0.61 ± 0.94 versus 0.11 ± 0.24% of live cells; p < 0.03, Kruskal-Wallis test), plasmablasts (0.06 ± 0.26 versus 0.00 ± 0.00% of live cells; p < 0.055, Kruskal-Wallis test), and memory B cells (0.62 ± 1.26 versus 0.05 ± 0.15% of live cells; p < 0.02, Kruskal-Wallis test)., Conclusion: Our study identified increased frequencies of different B-cell subtypes in the mucosa of patients with CRSwNP but not in the peripheral blood. We also found that patients with CRSwNP had significantly increased B-cell subtypes compared with the patients with CRSsNP and the controls. These results implied a potential role for mucosal B cells in the ongoing inflammation in patients with CRSwNP.
- Published
- 2018
- Full Text
- View/download PDF
23. Increased IL-13 expression is independently associated with neo-osteogenesis in patients with chronic rhinosinusitis.
- Author
-
Oue S, Ramezanpour M, Paramasivan S, Miljkovic D, Cooksley CM, Bassiouni A, Ou J, Psaltis AJ, Wormald PJ, and Vreugde S
- Subjects
- Bone and Bones metabolism, Chronic Disease, Eosinophils immunology, Female, Humans, Interleukin-13 genetics, Male, Middle Aged, Nasal Mucosa metabolism, Neutrophils immunology, Osteoblasts metabolism, Rhinitis immunology, Sinusitis immunology, Interleukin-13 metabolism, Osteogenesis physiology, Rhinitis metabolism, Sinusitis metabolism
- Published
- 2017
- Full Text
- View/download PDF
24. Therapy of Sinonasal Microbiome in CRS: A Critical Approach.
- Author
-
Psaltis AJ and Wormald PJ
- Subjects
- Animals, Chronic Disease, Dysbiosis therapy, Humans, Probiotics therapeutic use, Rhinitis therapy, Sinusitis therapy, Treatment Outcome, Dysbiosis microbiology, Microbiota, Rhinitis microbiology, Sinusitis microbiology
- Abstract
Purpose of Review: Perturbations in local microbiota have been demonstrated in many chronic inflammatory diseases including chronic rhinosinusitis (CRS). The purpose of this paper is to review the latest microbiome research as it pertains to CRS and establish whether there is any evidence supporting the microbiome hypothesis for CRS. Treatment factors that may influence the sinonasal microbiome as well as the role of probiotics are also discussed., Recent Findings: Despite significant heterogeneity in study design, tissue sampling, processing and bioinformatics analysis, consistent findings have emerged from the recent literature. Healthy individuals and CRS patients have similar overall bacterial burden of disease and share many common phylum. CRS patients, however, routinely show reductions in markers of biodiversity. Both medical and surgical treatments appear to influence the sinonasal microbiome, with certain bacterial strains associated with better treatment outcomes. The presence of microbial dysbiosis in CRS is now supported by numerous studies. Whether this dysbiosis is a cause or rather an association of the disease process still remains unclear. Although probiotic therapies show early promise, much larger studies are required to establish their real role as a treatment for CRS.
- Published
- 2017
- Full Text
- View/download PDF
25. Discordant frequencies of tissue-resident and circulating CD180-negative B cells in chronic rhinosinusitis.
- Author
-
Miljkovic D, Ou J, Kirana C, Hulse KE, Hauben E, Psaltis A, Wormald PJ, and Vreugde S
- Subjects
- Antigens, CD genetics, Antigens, Surface genetics, Antigens, Surface immunology, Chronic Disease, Humans, Immunoglobulin G blood, Nasal Mucosa immunology, Nasal Polyps genetics, RNA, Messenger metabolism, Rhinitis blood, Sinusitis blood, Toll-Like Receptor 4 genetics, Toll-Like Receptor 4 immunology, Antigens, CD immunology, B-Lymphocytes immunology, Nasal Polyps immunology, Rhinitis immunology, Sinusitis immunology
- Abstract
Background: The unconventional toll-like receptor (TLR) CD180 is implicated in chronic inflammatory diseases; however, its role in chronic rhinosinusitis (CRS) has yet to be investigated. Here we study the expression of CD180, its homologue TLR4 and myeloid differentiation factor 1 (MD1) on mucosal and systemic immune cell populations in relation to serum immunoglobulin G (IgG) levels., Methods: A total of 70 patients were recruited to the study. Mucosal and peripheral blood samples were prospectively collected from CRS patients and non-CRS controls without evidence of sinus disease. The expression of TLR4, MD1, and CD180 was investigated using qualitative real-time polymerase chain reaction (qRT-PCR), immunohistochemistry, and flow cytometry. Serum IgG levels were determined using enzyme-linked immunosorbent assay (ELISA)., Results: CRS with nasal polyps (CRSwNP) patients had significantly increased messenger RNA (mRNA) expression of CD180 and MD1 compared to controls (5.54-fold and 2.1-fold, respectively, p < 0.01). B cells lacking CD180 were lower in CRSwNP tissue compared to CRS without nasal polyps (CRSsNP) and controls (21.07 ± 6.41 vs 41.61 ± 7.82 vs 40.06 ± 8.06; p < 0.01) but higher in blood (39.18 ± 8.3 vs 17.95 ± 7.82 and 12.49 ± 4.92; p ≤ 0.05)., Conclusion: Changes in mucosal and peripheral CD180-expressing B cells were identified in CRSwNP patients compared to CRSsNP and controls. This suggests a role for these cells in the dysregulated immune response in these patients., (© 2017 ARS-AAOA, LLC.)
- Published
- 2017
- Full Text
- View/download PDF
26. Tertiary lymphoid organs in recalcitrant chronic rhinosinusitis.
- Author
-
Lau A, Lester S, Moraitis S, Ou J, Psaltis AJ, McColl S, Rischmueller M, Wormald PJ, and Vreugde S
- Subjects
- Chronic Disease, Humans, Lymphoid Tissue immunology, Lymphoid Tissue pathology, Rhinitis immunology, Rhinitis pathology, Sinusitis immunology, Sinusitis pathology
- Published
- 2017
- Full Text
- View/download PDF
27. Biofilm and Osteitis in Refractory Chronic Rhinosinusitis.
- Author
-
Zhao YC and Wormald PJ
- Subjects
- Chronic Disease, Disease Management, Humans, Prognosis, Biofilms drug effects, Biofilms growth & development, Nasal Bone pathology, Osteitis immunology, Osteitis physiopathology, Osteitis surgery, Rhinitis diagnosis, Rhinitis physiopathology, Sinusitis diagnosis, Sinusitis physiopathology, Sinusitis therapy
- Abstract
Our understanding of chronic rhinosinusitis (CRS) show biofilm and osteitis play a role in the disease's pathogenesis and refractory. Studies point to its role in pathogenesis and poor prognosis. Outside the research laboratory, biofilm detection remains difficult and specific treatment remains elusive. It is believed that osteitis is a nidus of inflammation and occurs more commonly in patients with refractory CRS. However, osteitis may be exacerbated by surgery and a marker of refractory disease, not a causative agent. Surgery remains the mainstay treatment for biofilm and osteitis with mechanical disruption and removal of disease load providing the most effective treatment., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
28. Sinus Penetration of a Pulsating Device Versus the Classic Squeeze Bottle in Cadavers Undergoing Sinus Surgery.
- Author
-
Chen PG, Murphy J, Alloju LM, Boase S, and Wormald PJ
- Subjects
- Cadaver, Chronic Disease, Fluorescein, Fluorescent Dyes, Humans, Video Recording, Endoscopy, Rhinitis therapy, Sinusitis therapy, Therapeutic Irrigation instrumentation
- Abstract
Objectives: Nasal irrigation is standard in the management of chronic rhinosinusitis both before and after surgical intervention. Numerous irrigation devices are commercially available. The aim of this study was to compare the efficacy of a handheld pulse irrigation device against the gold standard manual squeeze bottle after endoscopic sinus surgery (ESS)., Methods: Five cadaveric specimens were prepared with video visualization ports into each sinus. Endoscopic sinus surgery was performed on each cadaver from minimal to maximal dissection. Sinuses were irrigated with fluorescein solution using both devices following each dissection. The irrigations were video recorded. A blinded independent observer scored each irrigation according to a defined scale., Results: Comparison of the 2 devices using an intraclass correlation coefficient (ICC = 0.39) showed the 2 systems differed. Observation of individual sinuses showed the squeeze bottle consistently provided greater irrigation in the maxillary (P < .006), frontal (P < .0001), and sphenoid (P < .0001) sinuses. Pulse irrigation improved only in the maxillary sinus following ESS., Conclusion: The squeeze bottle consistently demonstrated superior irrigation in both native and operated conditions. Interestingly, saline penetration was not significantly improved after opening of the frontal and sphenoid sinuses. This is likely due to decreased backpressure in the nasal passage after opening the sinus cavities., (© The Author(s) 2016.)
- Published
- 2017
- Full Text
- View/download PDF
29. Association of intracellular Staphylococcus aureus with prognosis in chronic rhinosinusitis.
- Author
-
Ou J, Drilling A, Singhal D, Tan NC, Wallis-Hill D, Vreugde S, Psaltis AJ, and Wormald PJ
- Subjects
- Adult, Aged, Chronic Disease, Endoscopy, Female, Humans, Male, Middle Aged, Nasal Mucosa pathology, Nasal Mucosa surgery, Nasal Polyps diagnosis, Nasal Polyps pathology, Nasal Polyps surgery, Postoperative Period, Prognosis, Rhinitis diagnosis, Rhinitis pathology, Rhinitis surgery, Sinusitis diagnosis, Sinusitis pathology, Sinusitis surgery, Staphylococcal Infections diagnosis, Staphylococcal Infections microbiology, Staphylococcal Infections pathology, Staphylococcal Infections surgery, Young Adult, Nasal Mucosa microbiology, Nasal Polyps microbiology, Rhinitis microbiology, Sinusitis microbiology, Staphylococcus aureus isolation & purification
- Abstract
Background: Staphylococcus aureus (S. aureus) has been shown to exist within nasal epithelial cells in chronic rhinosinusitis (CRS) patients. This study investigates the localization of intracellular S. aureus (ICSA) in CRS patients, the associated histopathology changes, and their effect on long-term postoperative outcomes., Methods: A prospective study of patients with CRS with and without polyps and control patients (n = 25, 15, and 8, respectively) undergoing endoscopic sinus surgery was performed. Validated patient reported symptom scores and objective endoscopic scores were collected preoperatively and 12 months postoperatively. Mucosal tissue samples were collected and examined for the presence of ICSA using immunohistochemical analysis. Tissue also underwent routine hematoxylin and eosin and Sirius Red staining to evaluate the inflammatory cell load and extent of fibrosis., Results: ICSA appeared to localize to the perinuclear region of the pseudostratified columnar respiratory epithelium. ICSA was more prevalent in CRS without nasal polyps (CRSsNP) than in CRS with nasal polyps (CRSwNP) or controls (80% vs 56% vs 38%, respectively). ICSA positive status did not appear to influence symptom or endoscopic scores at the time of surgery nor 12 months postoperatively. Lymphocytes and total inflammatory cells were significantly increased in ICSA(+) group than ICSA(-) groups (36.4 vs 22.4 cells/area and 53.8 vs 29.1 cells/area, respectively). There was no difference found in fibrosis., Conclusion: This study indicated that ICSA was most prevalent in CRSsNP patients and was associated with increased lymphocytia and total inflammatory cells but not with worse symptomatology, endoscopy results, or basement membrane (BM) thickening., (© 2016 ARS-AAOA, LLC.)
- Published
- 2016
- Full Text
- View/download PDF
30. T regulatory and Th17 cells in chronic rhinosinusitis with polyps.
- Author
-
Miljkovic D, Psaltis A, Wormald PJ, and Vreugde S
- Subjects
- Adult, Aged, Chronic Disease, Female, Flow Cytometry, Humans, Hypersensitivity immunology, Male, Middle Aged, Nasal Mucosa immunology, Nasal Polyps immunology, Rhinitis immunology, Sinusitis immunology, T-Lymphocytes, Regulatory immunology, Th17 Cells immunology
- Abstract
Background: Chronic rhinosinusitis (CRS) is categorized into 2 types based on the absence (CRSsNP) and presence of nasal polyps (CRSwNP). Although CRSsNP patients lack nasal polyps, the mucosa may show variable degrees of polypoid change. This raises the question of whether or not the classification system is an over simplification and that CRSsNP and CRSwNP only represent 2 phenotypic extremes along a broader spectrum of immunologically different disease processes. To investigate this, adaptive and innate immune cells were compared in the different tissue types within CRSsNP and CRSwNP patients., Methods: Tissue from 15 CRSwNP, 6 CRSsNP, and 8 healthy control patients was obtained prospectively. Nonpolypoid mucosa, polypoid tissues, and polyps were obtained at the time of endoscopic sinus surgery and analyzed using flow cytometry for various adaptive and innate immune cell subsets., Results: In the polyps from CRSwNP patients there were significantly more T regulatory (Treg) cells (12.86 ± 12.60 vs 2.83 ± 4.68) and Th17 cells (16.12 ± 11.75 vs 2.31 ± 2.13) compared to the polypoid tissue from CRSsNP patients. Cellular infiltrates in the nonpolypoid or polypoid mucosa of the different patient categories showed no difference in CRSwNP, CRSsNP and control groups., Conclusion: This observational study identified an increase in Treg and Th17 cells in CRSwNP patients implying that these cells may be implicated in polyp development. Importantly it also identified a similar inflammatory infiltrate in nonpolyp or polypoid mucosa across control, CRSsNP, and CRSwNP groups inferring that polyps should be sampled when studying CRSwNP., (© 2016 ARS-AAOA, LLC.)
- Published
- 2016
- Full Text
- View/download PDF
31. Enumerating Virus-Like Particles and Bacterial Populations in the Sinuses of Chronic Rhinosinusitis Patients Using Flow Cytometry.
- Author
-
Carlson-Jones JA, Paterson JS, Newton K, Smith RJ, Dann LM, Speck P, Mitchell JG, and Wormald PJ
- Subjects
- Body Fluids, Chronic Disease, Fluorescence, Humans, Paranasal Sinuses virology, Bacteria growth & development, Flow Cytometry methods, Paranasal Sinuses microbiology, Rhinitis microbiology, Rhinitis virology, Sinusitis microbiology, Sinusitis virology, Virion physiology
- Abstract
There is increasing evidence to suggest that the sinus microbiome plays a role in the pathogenesis of chronic rhinosinusitis (CRS). However, the concentration of these microorganisms within the sinuses is still unknown. We show that flow cytometry can be used to enumerate bacteria and virus-like particles (VLPs) in sinus flush samples of CRS patients. This was achieved through trialling 5 sample preparation techniques for flow cytometry. We found high concentrations of bacteria and VLPs in these samples. Untreated samples produced the highest average bacterial and VLP counts with 3.3 ± 0.74 x 10(7) bacteria ml(-1) and 2.4 ± 1.23 x 10(9) VLP ml(-1) of sinus flush (n = 9). These counts were significantly higher than most of the treated samples (p < 0.05). Results showed 10(3) and 10(4) times inter-patient variation for bacteria and VLP concentrations. This wide variation suggests that diagnosis and treatment need to be personalised and that utilising flow cytometry is useful and efficient for this. This study is the first to enumerate bacterial and VLP populations in the maxillary sinus of CRS patients. The relevance of enumeration is that with increasing antimicrobial resistance, antibiotics are becoming less effective at treating bacterial infections of the sinuses, so alternative therapies are needed. Phage therapy has been proposed as one such alternative, but for dosing, the abundance of bacteria is required. Knowledge of whether phages are normally present in the sinuses will assist in gauging the safety of applying phage therapy to sinuses. Our finding, that large numbers of VLP are frequently present in sinuses, indicates that phage therapy may represent a minimally disruptive intervention towards the nasal microbiome. We propose that flow cytometry can be used as a tool to assess microbial biomass dynamics in sinuses and other anatomical locations where infection can cause disease.
- Published
- 2016
- Full Text
- View/download PDF
32. Outcomes of revision endoscopic modified Lothrop procedure.
- Author
-
Morrissey DK, Bassiouni A, Psaltis AJ, Naidoo Y, and Wormald PJ
- Subjects
- Chronic Disease, Female, Humans, Male, Middle Aged, Recurrence, Reoperation, Retrospective Studies, Treatment Outcome, Endoscopy methods, Nasal Polyps surgery, Otorhinolaryngologic Surgical Procedures methods, Rhinitis surgery, Sinusitis surgery
- Abstract
Background: Endoscopic modified Lothrop procedure (EMLP) is used to treat patients who fail conventional sinus surgery. The failure rate of a primary EMLP is reported to be between 5% and 32%. The failure rate of revision EMLP has not been reported. We present our institutions data regarding the outcome of patients requiring revision EMLP., Methods: Data was collected prospectively. Patients undergoing primary EMLP between January 2001 and December 2013 with a minimum follow-up of 6 months were included. Information related to demographics, asthma status, aspirin sensitivity, 22-item Sino-Nasal Outcome Test (SNOT-22) score, Lund-Mackay scores, intraoperative findings, and endoscopic ostium assessment were collected., Results: There were 213 primary EMLPs completed with average follow-up of 36 months. The failure rate of primary EMLP was 8.9% (19/213), whereas the failure rate of revision EMLP was 21% (4/19). Risk factors for failure of primary EMLP included the presence of intraoperative pus, more than 5 previous sinus operations and aspirin-exacerbated respiratory disease (AERD). Revision of EMLP was undertaken primarily due to recurrence of nasal polyps or ostium stenosis. Those patients who underwent revision EMLP experienced symptomatic improvement and no major complications following the procedure., Conclusion: The failure rate of revision EMLP is 21% in our series. The majority of revisions were for nasal polyp recurrence. Revision EMLP is a safe and well-tolerated procedure in the small group of patients that require further surgery. Patients with intraoperative pus present at their initial EMLP, more than 5 previous sinus operations, or AERD are at increased risk of failure., (© 2016 ARS-AAOA, LLC.)
- Published
- 2016
- Full Text
- View/download PDF
33. Editorial IFAR February 2016.
- Author
-
Wormald PJ
- Subjects
- Budesonide therapeutic use, Chronic Disease, Endoscopy, Humans, Rhinitis drug therapy, Sinusitis drug therapy, Surveys and Questionnaires, Olfaction Disorders diagnosis, Postoperative Complications prevention & control, Rhinitis diagnosis, Rhinoplasty, Sinusitis diagnosis
- Published
- 2016
- Full Text
- View/download PDF
34. Subepithelial inflammatory load and basement membrane thickening in refractory chronic rhinosinusitis with nasal polyposis: a histopathological study.
- Author
-
Bassiouni A, Ou J, Rajiv S, Cantero D, Vreugde S, and Wormald PJ
- Subjects
- Adult, Case-Control Studies, Chronic Disease, Female, Humans, Inflammation immunology, Male, Middle Aged, Nasal Mucosa pathology, Nasal Polyps diagnosis, Nasal Polyps surgery, Reoperation, Retrospective Studies, Rhinitis diagnosis, Rhinitis surgery, Rhinoplasty, Sinusitis diagnosis, Sinusitis surgery, Basement Membrane pathology, Eosinophils immunology, Nasal Mucosa immunology, Nasal Polyps pathology, Postoperative Complications pathology, Rhinitis pathology, Sinusitis pathology
- Abstract
Background: A subgroup of chronic rhinosinusitis with nasal polyps (CRSwNP) patients is refractory to optimal surgical therapy and requires multiple revision sinus operations. Studies have shown that mucosal eosinophilia correlates with disease severity. We hypothesized that a high-grade tissue inflammatory load is associated with these refractory patients., Methods: A single-surgeon, retrospective case-control study comparing 20 CRSwNP patients requiring a second surgery during follow-up (refractory group) vs a matched cohort of 20 CRSwNP patients without needing further revision surgery (control group). Hematoxylin and eosin (H&E)-stained tissue harvested intraoperatively (×2 for the refractory group) were recalled for histopathological examination of subepithelial inflammation and basement membrane (BM) thickness., Results: The refractory group had a significantly higher average eosinophil count (49 vs 18), relative eosinophilia (55% vs 32%) as well as total inflammatory cell count (86 vs 49) than the control group (p < 0.05). However within the refractory group, the eosinophil-lymphocyte ratio was reduced from their first to their second (revision) surgeries whereas the total averaged inflammatory cell count remained unchanged. No significant difference in BM thickness was found between the groups., Conclusion: These findings suggest that a higher inflammatory and eosinophilic load is associated with refractory disease and thus may be useful in predicting need for future revision surgery in CRSwNP., (© 2015 ARS-AAOA, LLC.)
- Published
- 2016
- Full Text
- View/download PDF
35. Innate lymphoid type 2 cells in chronic rhinosinusitis.
- Author
-
Vreugde S and Wormald PJ
- Subjects
- Animals, Chronic Disease, Humans, Interleukin-13 immunology, Lymphocytes pathology, Rhinitis pathology, Sinusitis pathology, Immunity, Innate, Lymphocytes immunology, Rhinitis immunology, Sinusitis immunology
- Abstract
Purpose of Review: Innate lymphoid type 2 cells (ILC2) have a critical role in the initiation and regulation of type 2 immune responses and are recognized as an important source of type-2 cytokines. Here, we present recent findings of the role of ILC2 in the integration, processing, and coordination of innate and adaptive immune processes and focus on the potential role of ILC2 in the context of chronic rhinosinusitis., Recent Findings: Recent research has shown the complex crosstalk that occurs between ILC2 and different innate and adaptive immune cell types with a critical role for ILC2 not only in mounting type 2 immune responses at barrier surfaces, but also in tissue repair responses and normal homeostatic functions. ILC2 research in a disease context has brought important insights in particular in the context of allergic inflammatory diseases, emphasizing a critical role for ILC2 and in particular ILC2-derived IL-13 in diseases of the upper and lower airways such as asthma., Summary: The identification and characterization of ILC2 in the context of health and disease have brought a wealth of new knowledge into the mechanisms of type 2 immune responses. This is relevant to diverse disorders, including asthma, chronic rhinosinusitis, atopic dermatitis, fibrosis, helminth repulsion, and obesity.
- Published
- 2016
- Full Text
- View/download PDF
36. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis.
- Author
-
Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM, Batra PS, Bernal-Sprekelsen M, Bhattacharyya N, Chandra RK, Chiu A, Citardi MJ, Cohen NA, DelGaudio J, Desrosiers M, Dhong HJ, Douglas R, Ferguson B, Fokkens WJ, Georgalas C, Goldberg A, Gosepath J, Hamilos DL, Han JK, Harvey R, Hellings P, Hopkins C, Jankowski R, Javer AR, Kern R, Kountakis S, Kowalski ML, Lane A, Lanza DC, Lebowitz R, Lee HM, Lin SY, Lund V, Luong A, Mann W, Marple BF, McMains KC, Metson R, Naclerio R, Nayak JV, Otori N, Palmer JN, Parikh SR, Passali D, Peters A, Piccirillo J, Poetker DM, Psaltis AJ, Ramadan HH, Ramakrishnan VR, Riechelmann H, Roh HJ, Rudmik L, Sacks R, Schlosser RJ, Senior BA, Sindwani R, Stankiewicz JA, Stewart M, Tan BK, Toskala E, Voegels R, Wang de Y, Weitzel EK, Wise S, Woodworth BA, Wormald PJ, Wright ED, Zhou B, and Kennedy DW
- Subjects
- Acute Disease, Child, Chronic Disease, Humans, Nasal Polyps physiopathology, Rhinitis physiopathology, Sinusitis physiopathology, Consensus, Evidence-Based Medicine, Nasal Polyps therapy, Rhinitis therapy, Sinusitis therapy
- Abstract
Background: The body of knowledge regarding rhinosinusitis(RS) continues to expand, with rapid growth in number of publications, yet substantial variability in the quality of those presentations. In an effort to both consolidate and critically appraise this information, rhinologic experts from around the world have produced the International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR:RS)., Methods: Evidence-based reviews with recommendations(EBRRs) were developed for scores of topics, using previously reported methodology. Where existing evidence was insufficient for an EBRR, an evidence-based review (EBR)was produced. The sections were then synthesized and the entire manuscript was then reviewed by all authors for consensus., Results: The resulting ICAR:RS document addresses multiple topics in RS, including acute RS (ARS), chronic RS (CRS)with and without nasal polyps (CRSwNP and CRSsNP), recurrent acute RS (RARS), acute exacerbation of CRS (AECRS), and pediatric RS., Conclusion: As a critical review of the RS literature, ICAR:RS provides a thorough review of pathophysiology and evidence-based recommendations for medical and surgical treatment. It also demonstrates the significant gaps in our understanding of the pathophysiology and optimal management of RS. Too often the foundation upon which these recommendations are based is comprised of lower level evidence. It is our hope that this summary of the evidence in RS will point out where additional research efforts may be directed., (© 2016 ARS-AAOA, LLC.)
- Published
- 2016
- Full Text
- View/download PDF
37. The bacterial microbiome in chronic rhinosinusitis: Richness, diversity, postoperative changes, and patient outcomes.
- Author
-
Cleland EJ, Bassiouni A, Vreugde S, and Wormald PJ
- Subjects
- Acinetobacter, Biodiversity, Chronic Disease, Female, Humans, Male, Paranasal Sinuses surgery, Postoperative Period, Propionibacterium acnes, Staphylococcus epidermidis, Treatment Outcome, Endoscopy, Microbiota, Paranasal Sinuses microbiology, Rhinitis microbiology, Sinusitis microbiology
- Abstract
Background: The bacterial microbiome in chronic rhinosinusitis (CRS) remains poorly understood. Microorganisms are believed to be important contributors to the inflammatory response seen in these patients., Objective: To examine the bacterial CRS microbiome by using a pyrosequencing technique and determine the diversity, richness, prevalence, and abundance of bacterial species in these patients. Furthermore, the postoperative changes that occur in the microbiome and correlations with patient outcomes are assessed., Methods: Swabs were collected from 23 patients with CRS and 11 controls during surgery. Further postoperative swabs were collected in the CRS group. Bacterial DNA was extracted from the swabs and then sequenced by using 16S ribosomal DNA bacterial tag-encoded FLX amplicon pyrosequencing., Results: A total of 456 unique bacterial species were detected. No difference was seen for richness or diversity between the study groups (p > 0.05). Diversity declined after surgery in the CRS group (p = 0.01). Propionibacterium acnes and Staphylococcus epidermidis were the most prevalent species. Several significant differences were determined for prevalence and mean relative abundance (MRA) between the study groups. In particular, Acinetobacter johnsonii was more prevalent and had a higher MRA in the controls. Furthermore, the MRA of this species increased after surgery and was associated with improved quality of life., Conclusion: This study characterized the sinonasal microbiome in a group of controls and patients with CRS. Important differences in diversity, prevalence, abundance, and temporal changes were described. Of great interest is the potential association between A. johnsonii and health. These findings provide new insights into the interplay between the microbiome and health in the paranasal sinuses.
- Published
- 2016
- Full Text
- View/download PDF
38. Topical colloidal silver as an anti-biofilm agent in a Staphylococcus aureus chronic rhinosinusitis sheep model.
- Author
-
Rajiv S, Drilling A, Bassiouni A, James C, Vreugde S, and Wormald PJ
- Subjects
- Animals, Anti-Bacterial Agents therapeutic use, Rhinitis microbiology, Sheep, Sinusitis microbiology, Staphylococcal Infections microbiology, Treatment Outcome, Biofilms drug effects, Disease Models, Animal, Rhinitis drug therapy, Silver therapeutic use, Sinusitis drug therapy, Staphylococcal Infections drug therapy, Staphylococcus aureus physiology
- Abstract
Background: Treatment of recalcitrant chronic rhinosinusitis (CRS) is a challenge with increasing antibiotic resistance, leading to re-emergence of topical therapies. The aim of this study was to assess safety and efficacy of topical colloidal silver solution for the treatment of Staphylococcus aureus biofilms in a sheep model., Methods: In the safety study, normal saline (control) and 30-ppm colloidal silver solution (test) was used to flush the frontal sinuses for 14 days in 8 sheep (4 sheep each). In the efficacy study, following frontal sinus infection with Staphylococcus aureus, sheep were treated with either control saline or topical silver solution of varying concentrations (30 ppm/20 ppm/10 ppm/5 ppm) for 5 days, with 4 sheep in each group. Blood silver level, full blood counts, and biochemical parameters were analyzed in both safety and efficacy studies. Sinus tissue was harvested for histological examination and ciliary structure analysis in safety and for biofilm biomass quantification by fluorescence in situ hybridization (FISH) technique and COMSTAT 2 software in the efficacy study. Results were analyzed using appropriate statistical tests., Results: Sheep treated with silver showed a significant decrease in biofilm biomass (0.004, 0.004, 0.004, and 0.007, in the 4 silver-treated groups, respectively) compared to saline control (0.175), p < 0.001. Although average blood silver levels were higher in the treated groups compared to controls (p < 0.05), blood counts and biochemical parameters were normal. Histology and ciliary structure analysis did not show any difference between control and treatment groups., Conclusion: Topical colloidal silver solution has effective antibiofilm activity in Staphylococcus aureus CRS in a sheep model and appears safe., (© 2015 ARS-AAOA, LLC.)
- Published
- 2015
- Full Text
- View/download PDF
39. Cousins, siblings, or copies: the genomics of recurrent Staphylococcus aureus infections in chronic rhinosinusitis.
- Author
-
Drilling A, Coombs GW, Tan HL, Pearson JC, Boase S, Psaltis A, Speck P, Vreugde S, and Wormald PJ
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents therapeutic use, Biofilms drug effects, Biofilms growth & development, Chronic Disease, Drug Resistance, Bacterial, Family, Female, Genomics, Humans, Male, Middle Aged, Recurrence, Retrospective Studies, Rhinitis drug therapy, Rhinitis microbiology, Siblings, Sinusitis drug therapy, Sinusitis microbiology, Species Specificity, Staphylococcal Infections drug therapy, Staphylococcal Infections microbiology, Young Adult, Paranasal Sinuses microbiology, Rhinitis diagnosis, Sinusitis diagnosis, Staphylococcal Infections diagnosis, Staphylococcus aureus isolation & purification
- Abstract
Background: Staphylococcus aureus infection is known to play a role in recalcitrant chronic rhinosinusitis (CRS). However, it is unknown if recurrent S. aureus infections are caused by the same strain or are due to independent acquisitions of different strains., Methods: Samples were collected from patients with CRS from July 2011 to August 2012. S. aureus was isolated from mucosal swabs and tissue specimens from patients who underwent surgery during the study period, or from swabs of areas of purulence taken in the postoperative period under endoscopic guidance. Pulsed-field gel electrophoresis was used to characterize S. aureus isolates., Results: Thirty-four patients were included in the study; 79% showed persistence of the same S. aureus strain in their paranasal sinuses (p = 0.001; H1 ≠ 50%). Furthermore, a significantly high frequency of patients with known biofilm status were positive for S. aureus biofilm (p = 0.002; H1 ≠ 50%). When patients were stratified according to disease evolution postsurgery, certain strains appeared to be more commonly associated with symptom persistence., Conclusion: The same S. aureus strain appears to persist in the paranasal sinuses of CRS patients despite multiple courses of culture-directed antibiotics. This suggests that conventional antimicrobial therapies in patients with CRS may not eliminate the organism. This may be partly explained by the formation of biofilms in the paranasal sinus region., (© 2014 ARS-AAOA, LLC.)
- Published
- 2014
- Full Text
- View/download PDF
40. Editorial: the annual Institute for Scientific Information(ISI).
- Author
-
Wormald PJ
- Subjects
- Adenocarcinoma surgery, Allergy and Immunology, Humans, Pituitary Neoplasms surgery, Rhinitis drug therapy, Sinusitis drug therapy, Sleep Wake Disorders, Steroids therapeutic use, Endoscopy, Rhinitis surgery, Sinusitis surgery
- Published
- 2014
- Full Text
- View/download PDF
41. The fungal microbiome in chronic rhinosinusitis: richness, diversity, postoperative changes and patient outcomes.
- Author
-
Cleland EJ, Bassiouni A, Boase S, Dowd S, Vreugde S, and Wormald PJ
- Subjects
- Biodiversity, Chronic Disease, DNA, Fungal analysis, DNA, Ribosomal analysis, Female, Fungi classification, Fungi genetics, Humans, Male, Middle Aged, Postoperative Period, Fungi isolation & purification, Microbiota, Rhinitis microbiology, Rhinitis surgery, Sinusitis microbiology, Sinusitis surgery
- Abstract
Background: Our understanding of fungi in chronic rhinosinusitis (CRS) has been limited by previously employed detection techniques. This study examines the fungal component of the microbiome in CRS patients and controls using a highly sensitive culture-independent molecular technique. The aims of this study include the characterization of fungal richness, prevalence, abundance, temporal changes, and their relationship with patient outcomes., Methods: Swabs were collected from the sinuses of 23 CRS patients and 11 controls. Collection occurred intraoperatively, and at 6 and 12 weeks postoperatively. DNA was extracted from the swabs and fungal outcomes were determined through 18S ribosomal DNA (rDNA) fungal tag-encoded FLX amplicon pyrosequencing., Results: Fungi were ubiquitous to all patients. A total of 207 fungal genera were detected, with a mean sample richness of 8.18 and 12.14 in the control and CRS groups, respectively. Malassezia was detected in all patients at surgery and was also the most abundant. Postoperatively, fungal richness decreased (p < 0.05) and was associated with declines in the prevalence of Fusarium and Neocosmospora (p < 0.05). Neocosmospora was also less abundant postoperatively (p < 0.05). No correlations were found with quality of life., Conclusion: This is the first study to use a highly sensitive pyrosequencing technique to reveal the true diversity of fungi in the sinuses of CRS patients and postoperative changes in richness. The presence of Malassezia, a genus not previously described in the sinuses, is of great interest, and its potential as a disease modifier should see further investigation given its association with atopic disease., (© 2014 ARS-AAOA, LLC.)
- Published
- 2014
- Full Text
- View/download PDF
42. Probiotic manipulation of the chronic rhinosinusitis microbiome.
- Author
-
Cleland EJ, Drilling A, Bassiouni A, James C, Vreugde S, and Wormald PJ
- Subjects
- Animals, Cell Count, Chronic Disease, Goblet Cells pathology, Hyperplasia, Mice, Mice, Inbred C57BL, Microbiota, Rhinitis microbiology, Rhinitis pathology, Staphylococcal Infections microbiology, Staphylococcal Infections pathology, Probiotics therapeutic use, Rhinitis therapy, Staphylococcal Infections therapy, Staphylococcus aureus, Staphylococcus epidermidis
- Abstract
Background: Staphylococcus aureus (SA) is a key pathogenic component of the chronic rhinosinusitis (CRS) microbiome and is associated with increased disease severity and poor postoperative outcomes. Probiotic treatments potentially offer a novel approach to the management of pathogenic bacteria in these recalcitrant patients through supporting a healthy community of commensal species. This study aims to investigate the probiotic properties of Staphylococcus epidermidis (SE) against SA in a mouse model of sinusitis., Methods: Twenty C57/BL6 mice received intranasal inoculations of phosphate buffered saline (PBS), SE, SA, or a combination of SE and SA (SE+SA) for 3 days. Following euthanasia, the mouse snouts were harvested and prepared for histological analysis. Counts of periodic acid-Schiff (PAS)-positive goblet cells were the primary outcome measure., Results: Goblet cell counts were significantly higher in both the SA and SE+SA groups compared to those receiving PBS or SE alone (p < 0.05). However, the SE+SA group demonstrated significantly lower goblet cell counts compared to the SA group (p < 0.05). Mice receiving SE alone did not show a significant difference to those receiving PBS (p > 0.05). The presence of SA postinoculation was confirmed by culture in both the SA and SE+SA groups., Conclusion: This study confirms the probiotic potential of SE against SA in a mouse model of sinusitis. Although the interactions that occur between many probiotic species and pathogens are yet to be fully understood, studies such as this support further exploration of ecologically-based treatment paradigms for the management of CRS., (© 2014 ARS-AAOA, LLC.)
- Published
- 2014
- Full Text
- View/download PDF
43. Colloidal silver: a novel treatment for Staphylococcus aureus biofilms?
- Author
-
Goggin R, Jardeleza C, Wormald PJ, and Vreugde S
- Subjects
- Biofilms growth & development, Biomass, Chronic Disease, Complementary Therapies, Drug Dosage Calculations, Humans, Microscopy, Confocal, Rhinitis complications, Sinusitis complications, Staphylococcal Infections complications, Staphylococcus aureus growth & development, Anti-Bacterial Agents pharmacology, Biofilms drug effects, Colloids pharmacology, Rhinitis therapy, Silver pharmacology, Sinusitis therapy, Staphylococcal Infections therapy, Staphylococcus aureus drug effects
- Abstract
Background: Colloidal silver is an alternative medicine consisting of silver particles suspended in water. After using this solution as a nasal spray, the symptoms of a previously recalcitrant Staphylococcus aureus (S. aureus)-infected chronic rhinosinusitis patient were observed to have improved markedly. The aim of this study was to determine whether colloidal silver has any direct bactericidal effects on these biofilms in vitro., Methods: S. aureus biofilms were grown from the ATCC 25923 reference strain on Minimum Biofilm Eradication Concentration (MBEC) device pegs, and treated with colloidal silver. Concentrations tested ranged from 10 to 150 μL colloidal silver diluted to 200 μL with sterile water in 50 μL cerebrospinal fluid (CSF) broth. Control pegs were exposed to equivalent volumes of CSF broth and sterile water. The sample size was 4 biomass values per treatment or control group. Confocal scanning laser microscopy and COMSTAT software were used to quantify biofilms 24 hours after treatment., Results: Significant differences from control were found for all concentrations tested bar the lowest of 10 μL colloidal silver in 200 μL. At 20 μL colloidal silver, the reduction in biomass was 98.9% (mean difference between control and treatment = -4.0317 μm(3) /μm(2) , p < 0.0001). A maximum biomass reduction of 99.8% was reached at both 100 and 150 μL colloidal silver (mean differences = -4.0681 and -4.0675μm(3) /μm(2) , respectively, p < 0.0001)., Conclusion: Colloidal silver directly attenuates in vitro S. aureus biofilms., (© 2014 ARS-AAOA, LLC.)
- Published
- 2014
- Full Text
- View/download PDF
44. Methylglyoxal-augmented manuka honey as a topical anti-Staphylococcus aureus biofilm agent: safety and efficacy in an in vivo model.
- Author
-
Paramasivan S, Drilling AJ, Jardeleza C, Jervis-Bardy J, Vreugde S, and Wormald PJ
- Subjects
- Administration, Topical, Animals, Biofilms growth & development, Biomass, Chronic Disease, Cilia microbiology, Disease Models, Animal, Honey adverse effects, Humans, Leptospermum, Metaplasia etiology, Microscopy, Confocal, Paranasal Sinuses microbiology, Pyruvaldehyde adverse effects, Rhinitis complications, Sheep, Sinusitis complications, Staphylococcal Infections complications, Biofilms drug effects, Cilia drug effects, Honey statistics & numerical data, Paranasal Sinuses drug effects, Paranasal Sinuses pathology, Pyruvaldehyde administration & dosage, Rhinitis therapy, Sinusitis therapy, Staphylococcal Infections therapy, Staphylococcus aureus physiology
- Abstract
Background: Bacterial biofilms are thought to contribute to recalcitrance in chronic rhinosinusitis (CRS) patients. Manuka honey (MH) and its active component methylglyoxal (MGO) have demonstrated antibiofilm activity in vitro. This study evaluated the safety and efficacy of these agents in an in vivo model., Methods: To assess safety, ovine frontal sinuses were flushed twice daily for 14 days. In each sheep, 1 sinus was flushed with a panel of MGO concentrations ranging from 0.5 to 7.2 mg/mL alone and flushed with a panel of with 16.5% wt/vol MH enriched with MGO at the same range of concentrations (0.5-7.2 mg/mL; designated MH/MGO). Contralateral sinuses were flushed with saline control. Tissue morphology was assessed histologically and with scanning electron microscopy. Efficacy was tested by developing Staphylococcus aureus biofilms in sheep sinuses. Twice-daily irrigation for 5 days was commenced with either saline, MGO (0.5-3.6 mg/mL) alone, or MH/MGO (with 0.5-3.6 mg/mL MGO). Biofilm biomass was compared between the groups (n = 4) using LIVE/DEAD BacLight staining and confocal scanning laser microscopy., Results: The results of the safety assessment, for normal sinuses treated with MGO alone or with MH/MGO (≤1.8 mg/mL) showed normal pseudostratified epithelium and cilia structure; however, higher concentrations caused cilia denudation and squamous metaplasia. As for efficacy, when compared to saline flush, treatment with MH/MGO at 0.9 mg/mL (0.608 ± 0.110 vs 0.316 ± 0.197 μm(3) /μm(2) , respectively; p = 0.015) and 1.8 mg/mL (0.676 ± 0.079 vs 0.114 ± 0.033 μm(3) /μm(2) , respectively; p = 0.001) significantly reduced biofilm biomass., Conclusion: Sinus irrigation with MH/MGO at MGO concentrations between 0.9 and 1.8 mg/mL is both safe to mucosa and efficacious against S. aureus biofilm. MH/MGO irrigation could represent a viable treatment option for recalcitrant CRS., (© 2014 ARS-AAOA, LLC.)
- Published
- 2014
- Full Text
- View/download PDF
45. Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients.
- Author
-
Drilling A, Morales S, Jardeleza C, Vreugde S, Speck P, and Wormald PJ
- Subjects
- Bacterial Load, Chronic Disease, Humans, Microscopy, Confocal, Rhinitis microbiology, Sinusitis virology, Staphylococcal Infections complications, Bacteriolysis, Biofilms growth & development, Biological Therapy, Rhinitis therapy, Sinusitis therapy, Staphylococcal Infections therapy, Staphylococcus Phages, Staphylococcus aureus virology
- Abstract
Background: Staphylococcus aureus is the most common organism in recalcitrant chronic rhinosinusitis (CRS) and is often resistant to traditional antibiotic therapy. Bacteriophages ("phages") are a potential candidate for a new, effective therapy. For phages to be useful in the setting of CRS, two minimum requirements must be presented: (1) phages must be effective against S. aureus biofilms and (2) phages must have a broad spectrum of activity. This study aimed to assess the in vitro activity of a phage cocktail (CockTail of Staphylococcus aureus specific bacteriophage [CT-SA]) against S. aureus biofilms and a broad panel of strains isolated from patients with CRS., Methods: The study examined 66 clinical isolates (CIs) of S. aureus. All isolates were tested for the susceptibility to phage lysis by spotting CT-SA onto bacterial lawns. To measure its effect on S. aureus biofilms, a minimum biofilm eradication concentration assay was used, using five S. aureus isolates. Biofilms of these isolates were grown, treated with CT-SA for 48 hours, fluorescently stained, and viewed using confocal scanning laser microscopy., Results: CT-SA lysed 62 of 66 (94%) CIs of S. aureus. CT-SA treatment yielded significant reductions in biofilm mass for 4/5 CIs tested and for ATCC 25923. Challenge of S. aureus with a single phage resulted in the emergence of bacteriophage-insensitive mutants (BIM) with a frequency of 10(-7), and challenge with CT-SA completely prevented their development., Conclusion: This study indicates that phage cocktail CT-SA can effectively eliminate S. aureus, in planktonic and biofilm forms, from the great majority of CIs from this hospital setting. In addition, its potential effect in preventing the emergence of BIMs was also established. Thus, CT-SA has the potential to treat S. aureus infection and biofilm in CRS patients.
- Published
- 2014
- Full Text
- View/download PDF
46. The bacteriology of chronic rhinosinusitis and the pre-eminence of Staphylococcus aureus in revision patients.
- Author
-
Cleland EJ, Bassiouni A, and Wormald PJ
- Subjects
- Adult, Aged, Aspirin adverse effects, Asthma complications, Chronic Disease, Female, Humans, Male, Middle Aged, Nasal Polyps complications, Reoperation, Retrospective Studies, Rhinitis complications, Sinusitis complications, Pseudomonas aeruginosa isolation & purification, Rhinitis microbiology, Sinusitis microbiology, Staphylococcus aureus isolation & purification
- Abstract
Background: The role of bacteria in the etiopathogenesis of chronic rhinosinusitis (CRS) remains an area of interest. The impact of surgery and factors such as the presence of polyps, asthma, and aspirin sensitivity on the bacterial state are poorly understood. To determine the effect of these factors, this study examines the culture results from a large cohort of CRS patients., Methods: This retrospective study used the culture results from 513 CRS patients, which were analyzed for species growth and compared to factors such as previous surgery, presence of polyps, aspirin sensitivity, and asthma. Univariate and multivariate logistic regression models were used for statistical analysis., Results: Eighty-three percent (83%) of patients had a positive culture result. The average number of isolates detected per patient was 0.95. S. aureus was the most frequently cultured organism (35%), followed by P. aeruginosa (9%), Haemophilus spp. (7%), and S. pneumonia (5%). Revision patients were more likely to grow S. aureus (p = 0.001), P. aeruginosa (p = 0.044) and have a positive culture (p = 0.001). Asthma was correlated with a positive culture (p = 0.039). No difference was determined between polyp and nonpolyp patients for any of the bacterial outcomes., Conclusion: This study highlights important factors in the bacteriology of CRS patients. S. aureus was the most prevalent species identified in our cohort, followed by P. aeruginosa. S. aureus rates of isolation were also significantly higher in patients undergoing revision surgery. No association was found between the presence of nasal polyposis and culture rates., (© 2013 ARS-AAOA, LLC.)
- Published
- 2013
- Full Text
- View/download PDF
47. Objective olfactory outcomes after revision endoscopic sinus surgery.
- Author
-
Hsu CY, Wang YP, Shen PH, Weitzel EK, Lai JT, and Wormald PJ
- Subjects
- Adult, Aged, Chronic Disease, Cohort Studies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Nasal Polyps complications, Olfaction Disorders etiology, Prognosis, Rhinitis complications, Sinusitis complications, Treatment Outcome, Nasal Polyps surgery, Nasal Surgical Procedures methods, Natural Orifice Endoscopic Surgery methods, Olfaction Disorders surgery, Rhinitis surgery, Sinusitis surgery, Smell
- Abstract
Background: Patients who suffer from hyposmia and anosmia report a negative effect on their overall quality of life. Smell disturbance of patients with chronic rhinosinusitis (CRS) can improve after endoscopic sinus surgery (ESS). Although several studies have shown that 50-83% of patients may notice an improvement in olfactory function after ESS, the olfactory improvement after revision ESS (RESS), especially by objective measurements, is still lacking., Methods: Olfactory function was assessed by the traditional Chinese version of the University of Pennsylvania Smell Identification Test (UPSIT-TC) preoperatively and postoperatively, recorded as smell identification test (SIT) score. Olfactory outcomes from anosmia to hyposmia/normosmia, or from hyposmia to normosmia, were considered as "improvement." Postoperative assessments were divided into two periods: period 1 (P1) is defined as >6 but <12 months postoperatively; period 2 (P2) is defined as >12 but <24 months postoperatively., Results: Thirty-two patients with smell disturbance preoperatively (period 0 [P0]) and confirmed by UPSIT-TC were enrolled into this study. Mean SIT score at P0 was 13.3; mean SIT score at P1 was 18.6; mean SIT score at P2 was 20.4. The presence of nasal polyps blocking the olfactory cleft were associated with better olfaction improvements (p < 0.05) as was the degree of mucosal swelling. The overall improvement rates were 44.8 and 47.8% at P1 and P2, respectively., Conclusion: RESS resulted in objective evidence of olfactory improvement in approximately one-half of our cohort over 16 months of follow-up and offers a treatment option for an otherwise poor prognosis condition.
- Published
- 2013
- Full Text
- View/download PDF
48. The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection.
- Author
-
Boase S, Foreman A, Cleland E, Tan L, Melton-Kreft R, Pant H, Hu FZ, Ehrlich GD, and Wormald PJ
- Subjects
- Adult, Bacteria classification, Bacteria genetics, Biodiversity, Chronic Disease, Coinfection microbiology, Female, Fungi classification, Fungi genetics, Humans, Male, Microbiological Techniques methods, Middle Aged, Bacteria isolation & purification, Bacterial Physiological Phenomena, Biofilms growth & development, Fungi isolation & purification, Metagenome, Rhinitis microbiology, Sinusitis microbiology
- Abstract
Background: Bacteria and fungi are believed to influence mucosal inflammation in chronic rhinosinusitis (CRS). However their presence and relationship to disease is debated. This study used multiple detection methods to compare microbial diversity and microbial abundance in healthy and diseased sinonasal mucosa. The utility of contemporary detection methods is also examined., Methods: Sinonasal mucosa was analyzed from 38 CRS and 6 controls. Bacterial and fungal analysis was performed using conventional culture, molecular diagnostics (polymerase chain reaction coupled with electrospray ionization time-of-flight mass spectrometry) and fluorescence in situ hybridization., Results: Microbes were detected in all samples, including controls, and were often polymicrobial. 33 different bacterial species were detected in CRS, 5 in control patients, with frequent recovery of anaerobes. Staphylococcus aureus and Propionibacterium acnes were the most common organisms in CRS and controls, respectively. Using a model organism, FISH had a sensitivity of 78%, and a specificity of 93%. Many species were detected in both CRS and controls however, microbial abundance was associated with disease manifestation., Conclusions: This study highlights some cornerstones of microbial variations in healthy and diseased paranasal sinuses. Whilst the healthy sinus is clearly not sterile, it appears prevalence and abundance of organisms is critical in determining disease. Evidence from high-sensitivity techniques, limits the role of fungi in CRS to a small group of patients. Comparison with molecular analysis suggests that the detection threshold of FISH and culture is related to organism abundance and, furthermore, culture tends to select for rapidly growing organisms.
- Published
- 2013
- Full Text
- View/download PDF
49. Bacterial-induced epithelial damage promotes fungal biofilm formation in a sheep model of sinusitis.
- Author
-
Boase S, Jervis-Bardy J, Cleland E, Pant H, Tan L, and Wormald PJ
- Subjects
- Animals, Aspergillosis etiology, Bacterial Infections complications, Bacterial Toxins immunology, Chronic Disease, Cilia ultrastructure, Disease Models, Animal, Humans, Nasal Mucosa microbiology, Respiratory Mucosa microbiology, Respiratory Mucosa ultrastructure, Sheep, Aspergillosis immunology, Aspergillus fumigatus physiology, Bacterial Infections immunology, Biofilms growth & development, Nasal Mucosa immunology, Respiratory Mucosa immunology, Rhinitis immunology, Sinusitis immunology
- Abstract
Background: Fungal biofilms have been discovered in chronic rhinosinusitis (CRS) patients, but factors contributing to their establishment are obscure. A recent animal study showed bacterial co-inoculation was required. We examine the role of 4 bacterial species and a cilia toxin on fungal biofilm formation in a sheep sinusitis model. The importance of epithelial integrity on fungal biofilm formation is also examined., Methods: Forty-eight frontal sinuses were inoculated with Aspergillus fumigatus alone, with 1 of 4 bacteria, or a cilia toxin. Bacterial and fungal biofilm was determined using confocal scanning laser microscopy. Inflammation and cilia integrity were assessed using light microscopy and transmission electron microscopy, respectively., Results: No fungal biofilm formed when inoculated alone. Florid fungal biofilm developed in more than 75% of sinuses associated with bacterial biofilm of all species, except Haemophilus influenzae, which failed to establish bacterial biofilm. Fungal biofilm also established in association with cilia toxin. Significant cilial damage was incited by all bacterial biofilms and cilia toxin, and was associated with fungal proliferation. Fungal biofilm formation did not significantly increase mucosal inflammation or epithelial damage over that caused by the bacteria or cilia toxin alone., Conclusion: Bacterial biofilms cause sinonasal mucosal inflammation and epithelial injury, which provides conditions appropriate for fungal biofilm proliferation. The role of cilia in sinonasal mucosal defense against fungal organisms has been demonstrated. Without such an insult, fungal biofilms fail to proliferate in occluded sinuses. Improving cilial recovery postoperatively and treating bacterial biofilms may be key factors in reducing recalcitrance in allergic fungal rhinosinusitis patients., (© 2013 ARS-AAOA, LLC.)
- Published
- 2013
- Full Text
- View/download PDF
50. Intracellular Staphylococcus aureus: the Trojan horse of recalcitrant chronic rhinosinusitis?
- Author
-
Tan NC, Foreman A, Jardeleza C, Douglas R, Vreugde S, and Wormald PJ
- Subjects
- Adult, Aged, Aged, 80 and over, Biofilms growth & development, Chronic Disease, Endoscopy, Female, Follow-Up Studies, Humans, Intracellular Space microbiology, Male, Middle Aged, Recurrence, Rhinitis surgery, Sinusitis surgery, Staphylococcal Infections surgery, Staphylococcus aureus pathogenicity, Treatment Outcome, Young Adult, Rhinitis microbiology, Sinusitis microbiology, Staphylococcal Infections microbiology, Staphylococcus aureus physiology
- Abstract
Background: Despite recent evidence suggesting that Staphylococcus aureus exists within the sinonasal epithelium of chronic rhinosinusitis (CRS) patients, certain questions remain. The intracellular environment may provide a protective niche for pathogenic bacteria to evade host immunity and yet provide a reservoir for reinfection. To date, no studies have examined the impact of this bacterial phenotype; therefore, this study was designed to evaluate the role of intracellular S. aureus on postsurgical outcomes., Methods: This study included 51 patients undergoing endoscopic sinus surgery (ESS) for medically-recalcitrant CRS. Sinonasal mucosa harvested at the time of surgery was dually stained with fluorescent molecular probes and imaged using confocal scanning laser microscopy for biofilm and intracellular status. Patients were followed in their early and late postoperative course for evidence of ongoing disease and signs of clinical relapse., Results: Intracellular S. aureus was identified in 20 of 51 (39%) patients, and all were associated with surface biofilm. Biofilm alone was found in 16 of 51 (31%) patients and 15 of 51 (29%) patients had no evidence of S. aureus. Intracellular positive patients had a significantly higher risk of late clinical and microbiological relapse (p = 0.014). In this study, biofilm status without coexisting intracellular bacteria did not appear to impact on outcomes., Conclusion: Clinical and microbiological relapse of disease following ESS is significantly associated with intracellular S. aureus. Evidence suggests that this disease association is independent to surface biofilm status. Intracellular bacteria should be taken into consideration when designing novel treatment strategies to lessen the chance of reinfection., (© 2013 ARS-AAOA, LLC.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.